Human growth hormone (GH) is widely abused as a performance-enhancing anabolic drug by athletes and bodybuilders. However, the effects of GH on skeletal muscle mass, strength and fibre composition remain unclear. We therefore summarize in the following the current knowledge on the physiological role of GH in the regulation of skeletal muscle growth and function and evaluate its potential therapeutic potency as a muscle anabolic hormone. In states of GH deficiency, reduced muscle mass and strength are characteristic findings which can be reversed successfully by the supplementation of GH. In contrast, the currently available data suggest that GH administration alone or in combination with strength exercise has little, if any, effect on muscle volume, strength and fibre composition in non-GH-deficient healthy young individuals. This assumption is supported by the lack of evidence for a significant performance-enhancing effect of GH in athletes. However, further studies will be necessary to define patient populations which might benefit from GH treatment like frail elderly individuals in whom a GH-induced change into a more youthful muscle fibre composition has been reported.

Keywords:
Growth hormone, Muscle, Strength
1.
De Boer H, Blok GJ, van der Veen EA: Clinical aspects of growth hormone deficiency in adults. Endocr Rev 1995;16:63–86.
2.
Cuneo RC, Salomon F, Wiles CM, Sonksen PH: Skeletal muscle performance in adults with growth hormone deficiency. Horm Res 1990;33(suppl 4):55–60.
3.
Rutherford OM, Jones DA, Round JM, Preece MA: Changes in skeletal muscle after discontinuation of growth hormone treatment in young adults with hypopituitarism. Acta Paediatr Scand Suppl 1989;356:61–63.
4.
Hulthen L, Bengtsson BA, Sunnerhagen KS, Hallberg L, Grimby G, Johannsson G: GH is needed for the maturation of muscle mass and strength in adolescents. J Clin Endocrinol Metab 2001;86:4765–4770.
5.
Carroll PV, Christ ER, Bengtsson BA, Carlsson L, Christiansen JS, Clemmons D, Hintz R, Ho K, Laron Z, Sizonenko P, Sonksen PH, Tanaka T, Thorne M: Growth hormone deficiency in adulthood and the effects of growth hormone replacement: A review. Growth Hormone Research Society Scientific Committee. J Clin Endocrinol Metab 1998;83:382–395.
6.
Jorgensen JO, Pedersen SA, Thuesen L, Jorgensen J, Ingemann-Hansen T, Skakkebaek NE, Christiansen JS: Beneficial effects of growth hormone treatment in GH-deficient adults. Lancet 1989;i:1221–1225.
7.
Beshyah SA, Freemantle C, Shahi M, Anyaoku V, Merson S, Lynch S, Skinner E, Sharp P, Foale R, Johnston DG: Replacement treatment with biosynthetic human growth hormone in growth hormone-deficient hypopituitary adults. Clin Endocrinol (Oxf) 1995;42:73–84.
8.
Ter Maaten JC, de Boer H, Kamp O, Stuurman L, van der Veen EA: Long-term effects of growth hormone (GH) replacement in men with childhood-onset GH deficiency. J Clin Endocrinol Metab 1999;84:2373–2380.
9.
Jorgensen JO, Thuesen L, Muller J, Ovesen P, Skakkebaek NE, Christiansen JS: Three years of growth hormone treatment in growth hormone-deficient adults: Near normalization of body composition and physical performance. Eur J Endocrinol 1994;130:224–228.
10.
Johannsson G, Grimby G, Sunnerhagen KS, Bengtsson BA: Two years of growth hormone (GH) treatment increase isometric and isokinetic muscle strength in GH-deficient adults. J Clin Endocrinol Metab 1997;82:2877–2884.
11.
Sartorio A, Narici M, Conti A, Monzani M, Faglia G: Quadriceps and hand-grip strength in adults with childhood-onset growth hormone deficiency. Eur J Endocrinol 1995;132:37–41.
12.
Janssen YJ, Doornbos J, Roelfsema F: Changes in muscle volume, strength, and bioenergetics during recombinant human growth hormone (GH) therapy in adults with GH deficiency. J Clin Endocrinol Metab 1999;84:279–284.
13.
Cuneo RC, Salomon F, Wiles CM, Hesp R, Sonksen PH: Growth hormone treatment in growth hormone-deficient adults. I. Effects on muscle mass and strength. J Appl Physiol 1991;70:688–694.
14.
Staron RS, Johnson P: Myosin polymorphism and differential expression in adult human skeletal muscle. Comp Biochem Physiol B 1993;106:463–475.
15.
Daugaard JR, Laustsen JL, Hansen BS, Richter EA: Growth hormone induces muscle fibre type transformation in growth hormone-deficient rats. Acta Physiol Scand 1998;164:119–126.
16.
Ayling CM, Moreland BH, Zanelli JM, Schulster D: Human growth hormone treatment of hypophysectomized rats increases the proportion of type-1 fibres in skeletal muscle. J Endocrinol 1989;123:429–435.
17.
Loughna PT, Bates PC: Interactions between growth hormone and nutrition in hypophysectomised rats: Skeletal muscle myosin heavy chain mRNA levels. Biochem Biophys Res Commun 1994;198:97–102.
18.
Roy RR, Tri C, Grossman EJ, Talmadge RJ, Grindeland RE, Mukku VR, Edgerton VR: IGF-1, growth hormone, and/or exercise effects on non-weight-bearing soleus of hypophysectomized rats. J Appl Physiol 1996;81:302–311.
19.
Grossman EJ, Grindeland RE, Roy RR, Talmadge RJ, Evans J, Edgerton VR: Growth hormone, IGF-1, and exercise effects on non-weight-bearing fast muscles of hypophysectomized rats. J Appl Physiol 1997;83:1522–1530.
20.
Rutherford OM, Beshyah SA, Schott J, Watkins Y, Johnston DG: Contractile properties of the quadriceps muscle in growth hormone-deficient hypopituitary adults. Clin Sci (Lond) 1995;88:67–71.
21.
Whitehead HM, Gilliland JS, Allen IV, Hadden DR: Growth hormone treatment in adults with growth hormone deficiency: Effect on muscle fibre size and proportions. Acta Paediatr Scand Suppl 1989;356:65–67.
22.
Cuneo RC, Salomon F, Wiles CM, Round JM, Jones D, Hesp R, Sonksen PH: Histology of skeletal muscle in adults with GH deficiency: Comparison with normal muscle and response to GH treatment. Horm Res 1992;37:23–28.
23.
Bottinelli R, Narici M, Pellegrino MA, Kayser B, Canepari M, Faglia G, Sartorio A: Contractile properties and fiber type distribution of quadriceps muscles in adults with childhood-onset growth hormone deficiency. J Clin Endocrinol Metab 1997;82:4133–4138.
24.
Woodhouse LJ, Asa SL, Thomas SG, Ezzat S: Measures of submaximal aerobic performance evaluate and predict functional response to growth hormone (GH) treatment in GH-deficient adults. J Clin Endocrinol Metab 1999;84:4570–4577.
25.
Welle S, Thornton C, Statt M, McHenry B: Growth hormone increases muscle mass and strength but does not rejuvenate myofibrillar protein synthesis in healthy subjects over 60 years old. J Clin Endocrinol Metab 1996;81:3239–3243.
26.
Papadakis MA, Grady D, Black D, Tierney MJ, Gooding GA, Schambelan M, Grunfeld C: Growth hormone replacement in healthy older men improves body composition but not functional ability. Ann Intern Med 1996;124:708–716.
27.
Lange KH, Andersen JL, Beyer N, Isaksson F, Larsson B, Rasmussen MH, Juul A, Bulow J, Kjaer M: GH administration changes myosin heavy chain isoforms in skeletal muscle but does not augment muscle strength or hypertrophy, either alone or combined with resistance exercise training in healthy elderly men. J Clin Endocrinol Metab 2002;87:513–523.
28.
Thompson JL, Butterfield GE, Gylfadottir UK, Yesavage J, Marcus R, Hintz RL, Pearman A, Hoffman AR: Effects of human growth hormone, insulin-like growth factor 1, and diet and exercise on body composition of obese postmenopausal women. J Clin Endocrinol Metab 1998;83:1477–1484.
29.
Yarasheski KE, Zachwieja JJ, Campbell JA, Bier DM: Effect of growth hormone and resistance exercise on muscle growth and strength in older men. Am J Physiol 1995;268:E268–E276.
30.
Taaffe DR, Pruitt L, Reim J, Hintz RL, Butterfield G, Hoffman AR, Marcus R: Effect of recombinant human growth hormone on the muscle strength response to resistance exercise in elderly men. J Clin Endocrinol Metab 1994;79:1361–1366.
31.
Hennessey JV, Chromiak JA, DellaVentura S, Reinert SE, Puhl J, Kiel DP, Rosen CJ, Vandenburgh H, MacLean DB: Growth hormone administration and exercise effects on muscle fiber type and diameter in moderately frail older people. J Am Geriatr Soc 2001;49:852–858.
32.
Linderman JK, Gosselink KL, Booth FW, Mukku VR, Grindeland RE: Resistance exercise and growth hormone as countermeasures for skeletal muscle atrophy in hindlimb-suspended rats. Am J Physiol 1994;267:R365–R371.
33.
Carmeli E, Hochberg Z, Livne E, Lichtenstein I, Kestelboim C, Silbermann M, Reznick AZ: Effect of growth hormone on gastrocnemius muscle of aged rats after immobilization: Biochemistry and morphology. J Appl Physiol 1993;75:1529–1535.
34.
Goldberg AL, Goodman HM: Relationship between growth hormone and muscular work in determining muscle size. J Physiol 1969;200:655–666.
35.
Ullman M, Oldfors A: Effects of growth hormone on skeletal muscle. I. Studies on normal adult rats. Acta Physiol Scand 1989;135:531–536.
36.
Everitt AV, Terry V, Phillips MJ, Kerry HM, Shorey CD: Morphometric analysis of gastrocnemius muscle fiber size and fiber proportions in the hypophysectomized rat after prolonged administration of growth hormone or thyroxine. Growth Dev Aging 1996;60:85–93.
37.
Sonntag WE, Hylka VW, Meites J: Growth hormone restores protein synthesis in skeletal muscle of old male rats. J Gerontol 1985;40:689–694.
38.
Fryburg DA, Gelfand RA, Barrett EJ: Growth hormone acutely stimulates forearm muscle protein synthesis in normal humans. Am J Physiol 1991;260:E499–E504.
39.
Fryburg DA, Barrett EJ: Growth hormone acutely stimulates skeletal muscle but not whole-body protein synthesis in humans. Metabolism 1993;42:1223–1227.
40.
Copeland KC, Nair KS: Acute growth hormone effects on amino acid and lipid metabolism. J Clin Endocrinol Metab 1994;78:1040–1047.
41.
Yarasheski KE, Campbell JA, Smith K, Rennie MJ, Holloszy JO, Bier DM: Effect of growth hormone and resistance exercise on muscle growth in young men. Am J Physiol 1992;262:E261–E267.
42.
Yarasheski KE, Zachweija JJ, Angelopoulos TJ, Bier DM: Short-term growth hormone treatment does not increase muscle protein synthesis in experienced weightlifters. J Appl Physiol 1993;74:3073–3076.
43.
Manson JM, Smith RJ, Wilmore DW: Growth hormone stimulates protein synthesis during hypocaloric parenteral nutrition. Role of hormonal-substrate environment. Ann Surg 1988;208:136–142.
44.
Rudman D, Feller AG, Nagraj HS, Gergans GA, Lalitha PY, Goldberg AF, Schlenker RA, Cohn L, Rudman IW, Mattson DE: Effects of human growth hormone in men over 60 years old. N Engl J Med 1990;323:1–6.
45.
Lange KH, Isaksson F, Juul A, Rasmussen MH, Bulow J, Kjaer M: Growth hormone enhances effects of endurance training on oxidative muscle metabolism in elderly women. Am J Physiol Endocrinol Metab 2000;279:E989–E996.
46.
Yarasheski KE, Zachwieja JJ: Growth hormone therapy for the elderly: The fountain of youth proves toxic. JAMA 1993;270:1694.
47.
Deyssig R, Frisch H, Blum WF, Waldhor T: Effect of growth hormone treatment on hormonal parameters, body composition and strength in athletes. Acta Endocrinol (Copenh) 1993;128:313–318.
48.
Singh MA, Ding W, Manfredi TJ, Solares GS, O’Neill EF, Clements KM, Ryan ND, Kehayias JJ, Fielding RA, Evans WJ: Insulin-like growth factor 1 in skeletal muscle after weight-lifting exercise in frail elders. Am J Physiol 1999;277:E135–E143.
49.
Porter MM, Vandervoort AA, Lexell J: Aging of human muscle: Structure, function and adaptability. Scand J Med Sci Sports 1995;5:129–142.
50.
MacDougall JD, Elder GC, Sale DG, Moroz JR, Sutton JR: Effects of strength training and immobilization on human muscle fibres. Eur J Appl Physiol Occup Physiol 1980;43:25–34.
51.
Frontera WR, Meredith CN, O’Reilly KP, Knuttgen HG, Evans WJ: Strength conditioning in older men: Skeletal muscle hypertrophy and improved function. J Appl Physiol 1988;64:1038–1044.
52.
Taaffe DR, Jin IH, Vu TH, Hoffman AR, Marcus R: Lack of effect of recombinant human growth hormone (GH) on muscle morphology and GH-insulin-like growth factor expression in resistance-trained elderly men. J Clin Endocrinol Metab 1996;81:421–425.
53.
Brumback RA, Barr CE: Myopathy in acromegaly. A case study. Pathol Res Pract 1983;177:41–46.
54.
Wolf E, Wanke R, Schenck E, Hermanns W, Brem G: Effects of growth hormone overproduction on grip strength of transgenic mice. Eur J Endocrinol 1995;133:735–740.
55.
Nagulesparen M, Trickey R, Davies MJ, Jenkins JS: Muscle changes in acromegaly. Br Med J 1976;ii:914–915.
56.
Cheah JS, Chua SP, Ho CL: Ultrastructure of the skeletal muscles in acromegaly before and after hypophysectomy. Am J Med Sci 1975;269:183–187.
57.
Stern LZ, Payne CM, Hannapel LK: Acromegaly: Histochemical and electron microscopic changes in deltoid and intercostal muscle. Neurology 1974;24:589–593.
58.
Rickert VI, Pawlak-Morello C, Sheppard V, Jay MS: Human growth hormone: A new substance of abuse among adolescents? Clin Pediatr (Phila) 1992;31:723–726.
59.
Ehrnborg C, Bengtsson BA, Rosen T: Growth hormone abuse. Baillières Best Pract Res Clin Endocrinol Metab 2000;14:71–77.
60.
Jenkins PJ: Growth hormone and exercise: Physiology, use and abuse. Growth Horm IGF Res 2001;11(suppl A):S71–S77.
61.
Macintyre JG: Growth hormone and athletes. Sports Med 1987;4:129–142.
62.
Daugaard JR, Bramnert M, Manhem P, Endre T, Groop LC, Lofman M, Richter EA: Effect of 6 months of GH treatment on myosin heavy chain composition in GH-deficient patients. Eur J Endocrinol 1999;141:342–349.
© 2002 S. Karger AG, Basel
2002
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.